Article ID Journal Published Year Pages File Type
2724412 Journal of Pain and Symptom Management 2012 7 Pages PDF
Abstract

ContextPersistent pain after treatment for breast cancer (PPBCT) is a common side effect of breast cancer treatment, with prevalence as high as 50%. It is predominantly a neuropathic condition.ObjectivesThe aim of this cross-sectional, questionnaire-based study was to examine the emotional characteristics of patients with PPBCT in long-term breast cancer patients. A secondary objective was to characterize the risk factors and severity of that pain.MethodsFrom March 1, 2010 to April 9, 2010, long-term follow-up patients were invited to complete a questionnaire. This recorded their surgical and demographic data and ascertained whether they had PPBCT. If the patient had pain, she completed a range of validated self-report questionnaires and questions about the nature of the pain, including a visual analogue scale.ResultsOne hundred eleven patients completed the questionnaire; 33 (29.7%) patients reported chronic pain at a median time of 64 months postoperatively (interquartile range 54.25). Patients with persistent pain were not significantly more anxious (t105 = −0.369, P = 0.713) or depressed (t105 = 0.713, P = 0.507) than patients without pain. Patients with constant pain compared with intermittent pain were significantly more anxious (t25 = −3.460, P = 0.002). Preoperative pain conferred a fivefold increased risk of PPBCT (odds ratio [OR] = 5.17, 95% confidence interval [CI] = 1.79–14.97, P = 0.002); chemotherapy conferred a threefold increased risk (OR = 3.004, 95% CI = 1.22–7.40, P = 0.017).ConclusionWe have shown significant numbers of patients suffer from PPBCT. At a median time of 64.5 months, women with pain are not significantly more anxious or depressed than women without pain. Preoperative pain and chemotherapy have been highlighted as risk factors.

Related Topics
Life Sciences Neuroscience Neurology
Authors
, , , , , , ,